IMMUNOREACTIVE ENDOTHELIN-1 IN THE VITREOUS HUMOR AND EPIRETINAL MEMBRANES OF PATIENTS WITH PROLIFERATIVE DIABETIC RETINOPATHY
- 1 February 2007
- journal article
- research article
- Published by Wolters Kluwer Health in Retina
- Vol. 27 (2) , 222-235
Abstract
Purpose: To investigate the potential role of endothelin-1 (ET-1), a potent vasoconstrictor with mitogenic properties, in the pathogenesis of proliferative diabetic retinopathy (PDR). Methods: Plasma and vitreous samples were collected from normal patients (controls; n = 25), diabetic patients with PDR (n = 25), and diabetic patients with non-PDR (n = 25). The patients had to have epiretinal membranes (ERMs) or other ocular conditions that made them candidates for vitrectomy. Immunoreactive ET-1 (IR-ET-1) was assayed in plasma and vitreous samples by radioimmunoassay. IR-ET-1 was immunohistochemically localized in ERMs. Expression of endothelin receptors A (ETA) and B (ETB) was confirmed by reverse transcription–polymerase chain reaction analysis. Results: IR-ET-1 levels in plasma and vitreous samples from diabetic patients were higher (P < 0.0001) than those in samples from the control group. The levels for patients with PDR were even higher (P < 0.0001) than those for patients with non-PDR. Eyes with ERMs in the PDR group had the highest vitreous IR-ET-1 levels (14.67 ± 0.67 pg/mL). IR-ET-1 was localized in the cellular and stromal components of ERMs in diabetic and nondiabetic patients. Furthermore, the ETA and ETB receptors were expressed in both diabetic and nondiabetic ERMs. Conclusions: Diabetic patients with PDR and ERMs had the highest plasma and vitreous IR-ET-1 levels. ET-1 and its ETA and ETB receptors were present in ERMs. These data suggest that ET-1 is involved in diabetic vitreoretinal disease.Keywords
This publication has 43 references indexed in Scilit:
- Endothelin-1 Synthesis and Secretion in Human Retinal Pigment Epithelial Cells (ARPE-19): Differential Regulation by Cholinergics and TNF-αInvestigative Ophthalmology & Visual Science, 2003
- Dramatic Inhibition of Retinal and Choroidal Neovascularization by Oral Administration of a Kinase InhibitorThe American Journal of Pathology, 1999
- Diabetic RetinopathyAnnual Review of Public Health, 1996
- Cell-specificity and signaling pathway of endothelin-1 gene regulation by hypoxiaCardiovascular Research, 1995
- Cell-specificity and signaling pathway of endothelin-1 gene regulation by hypoxiaCardiovascular Research, 1995
- RETINAL OXYGEN DISTRIBUTIONRetina, 1995
- Vitreous levels of the insulin-like growth factors I and II, and the insulin-like growth factor binding proteins 2 and 3, increase in neovascular eye disease. Studies in nondiabetic and diabetic subjects.Journal of Clinical Investigation, 1993
- Increased Plasma Endothelin in NIDDM Patients With RetinopathyDiabetes Care, 1992
- Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptorNature, 1990
- Cloning and expression of a cDNA encoding an endothelin receptorNature, 1990